How Is The Market Feeling About Pacific Biosciences?

Pacific Biosciences's (NYSE:PACB) short percent of float has risen 8.87% since its last report. The company recently reported that it has 52.82 million shares sold short, which is 22.34% of all regula

BenzingaMay 22 10:15 ET

Pacific Biosciences Is Maintained at Equal-Weight by Morgan Stanley

Pacific Biosciences Is Maintained at Equal-Weight by Morgan Stanley

Dow JonesMay 15 10:38 ET

Express News | Morgan Stanley Maintains Equal-Weight on Pacific Biosciences, Lowers Price Target to $4

BenzingaMay 15 10:28 ET

Ambry Genetics And PacBio Selected By UCI And GREGoR Consortium To Support Pediatric Mendelian Genomics Research Center Program To Study Rare Diseases

Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., along with PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing sol

BenzingaMay 15 09:49 ET

Express News | Ambry Genetics and Pacbio Announce Collaboration to Sequence up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases

ReutersMay 15 09:09 ET

Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases

Consortium Selects Leading Genomics Companies to Support Pediatric Mendelian Genomics Research Center ProgramALISO VIEJO, Calif. and MENLO PARK, Calif., May 15, 2024 /PRNewswire/ --Ambry Genetics, a p

Pacific Biosciences of CaliforniaMay 15 00:00 ET